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Abstract
PURPOSE: To describe maternal and neonatal outcomes in pregnant women undergoing hemodialysis in a referral center in 
Brazilian Southeast side. METHODS: Retrospective and descriptive study, with chart review of all pregnancies undergoing 
hemodialysis that were followed-up at an outpatient clinic of high- risk prenatal care in Southeast Brazil. RESULTS: Among 
the 16 women identified, 2 were excluded due to follow-up loss. In 14 women described, hypertension was the most 
frequent cause of chronic renal failure (half of cases). The majority (71.4%) had performed hemodialysis treatment for 
more than one year and all of them underwent 5 to 6 hemodialysis sessions per week. Eleven participants had chronic 
hypertension, 1 of which was also diabetic, and 6 of them were smokers. Regarding pregnancy complications, 1 of 
the hypertensive women developed malignant hypertension (with fetal growth restriction and preterm delivery at 29 
weeks), 2 had acute pulmonary edema and 2 had abruption placenta. The mode of delivery was cesarean section 
in 9 women (64.3%). All neonates had Apgar score at five minutes above 7. CONCLUSIONS: To improve perinatal 
and maternal outcomes of women undergoing hemodialysis, it is important to ensure multidisciplinary approach in 
referral center, strict control of serum urea, hemoglobin and maternal blood pressure, as well as close monitoring of fetal 
well-being and maternal morbidities. Another important strategy is suitable guidance for contraception in these women.
Resumo 
OBJETIVOS: Descrever os resultados maternos e neonatais de mulheres grávidas que estavam em tratamento de 
hemodiálise em um centro de referência no Sudeste brasileiro. MÉTODOS: Estudo retrospectivo e descritivo, com 
revisão de prontuários de todas as gestações em hemodiálise, acompanhadas no pré-natal especializado da região 
Sudeste do Brasil. RESULTADOS: Entre as 16 mulheres identificadas, 2 foram excluídas devido à perda de seguimento. 
Das 14 descritas, a hipertensão foi a causa mais frequente de insuficiência renal crônica (50% dos casos). A maioria 
(71,4%) realizava tratamento de hemodiálise há mais de um ano e todas elas foram submetidas a 5 ou 6 sessões 
por semana. Onze mulheres tinham hipertensão crônica, 1 das quais também era diabética, e 6 eram fumantes. 
Em relação às complicações da gravidez, 1 das mulheres hipertensas desenvolveu hipertensão maligna (com restrição 
de crescimento fetal e parto prematuro com 29 semanas), 2 tiveram edema pulmonar agudo e 2 apresentaram 
descolamento prematuro de placenta. O tipo de parto foi cesariana em 9 mulheres (64,3%). Todos os recém-nascidos 
tiveram Apgar aos cinco minutos maior que 7. CONCLUSÕES: Para melhorar os resultados perinatais e maternos 
de mulheres em hemodiálise, é importante ter uma abordagem multidisciplinar em centro de referência, um controle 
rigoroso da uremia, hemoglobina e pressão arterial materna, bem como acompanhar de perto o bem-estar fetal e 
a morbidade materna. Outra estratégia importante é a orientação adequada para contracepção nessas mulheres.
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Introduction
The chronic kidney disease (CKD) affects 3% of 
women of childbearing age1. Pregnancy is a rare event in 
patients on dialysis due to hormonal alterations associated 
with its treatment and also low libido and high level of 
stress in the effected women.
However, changes in CKD therapy and advances in 
dialysis techniques have allowed an increase in fertility 
in these women over the last decades2-4, with a calcu-
lated frequency from 0.3 to 1.5% per year4. The rate 
of live births in this group also increased to 40-50%. 
Nevertheless, the neonatal mortality one remains high 
(8 to 13%)4,5.
In Brazil, the main causes of CKD are hypertension 
and diabetes, which are also the primary causes of admis-
sions to dialysis programs in developed countries. These 
diseases, and also glomerulonephritis, are amongst the 
three most frequent causes to CKD in Latin America6.
The first case report of pregnancy on a dialysis patient 
occurred in 1971 in a 35-year-old woman. Since then, 
other ones have been reported worldwide2,7.
It is important to consider that pregnancy may also 
aggravate CKD8. Physiological changes such as increased 
progesterone levels and uterine growth lead to ureteroc-
alyceal dilatation, greater urine stasis, and a higher chance 
of untreated asymptomatic bacteriuria and pyelonephritis 
that can have a significant impact on underlying CKD, 
worsening renal failure5.
Another functional alteration during pregnancy is 
a massive vasodilatation, resulting in decreased blood 
pressure and increased cardiac output, augmented plasma 
renal flow, and glomerular filtration rate (GFR), with 
a high excretion of glucose, amino acids, calcium, and 
protein2. This urinary excretion of protein, although 
physiological, when complicated by underlying condi-
tions, like hypertension and diabetes, can accelerate renal 
function loss in women with CKD2.
Among the most significant maternofetal compli-
cations in women with CKD, there are the following: 
hypertension and preeclampsia (occurring in 80% of the 
cases)5,7,9, anemia (with the need of blood transfusion), 
peritoneal infection, placental insufficiency, preterm 
labor, and stillbirth9,10. Another risk of dialysis during 
pregnancy is the common occurrence of maternal hy-
potension throughout the procedure, which can cause 
poor placental perfusion and fetal distress3. Other fetal 
complications are: congenital anomalies (tetralogy of 
Fallot, genital changes), low birth weight (LBW), fetal 
growth restriction (FGR), polyhydramnios, prematurity 
(present in 84% of the cases)9,10, electrolyte disturbance 
(hypocalcemia) due to osmotic diuresis5, and neonatal 
deaths9,10.
In order to improve perinatal outcomes, several 
guidelines for renal replacement therapy and adequate 
follow-up have been developed: attention to pre-conception 
creatinine; precise indication of dialysis, with increased 
number of procedures during pregnancy (five to seven 
per week) targeting an urea level of 30–50 mg/dL5,7,8; 
increased erythropoietin reposition with hemoglobin 
levels around 10–11 g/dL; severe control of electrolytes 
and blood pressure; prevention of urinary tract infection; 
and adequate fetal monitoring5. A multidisciplinary ap-
proach in a referral medical center is essential (i.e. with 
obstetrician, nephrologists, nutritionists)2,7.
Understanding the scenario of this condition and 
improving techniques of renal replacement in these women 
are necessary to meet the increase cases worldwide and to 
define procedures for a favorable outcome.
This study aims to evaluate perinatal outcomes and 
maternal complications in pregnant women under dialysis 
in a Brazilian high-risk reference center.
Methods
We performed a retrospective chart review of a 
case series with pregnant women undergoing dialysis 
followed in the high-risk outpatient clinic of the State 
University of Campinas (Unicamp), over a ten-year period 
(2003–2012). Such center is the referral unit for a large 
catchment area and accounts for around 2,800 deliveries 
per year. High-risk pregnancies are followed-up receiv-
ing specialists’ support, with written protocols for the 
conditions considered.
For this study, a specific form was created to retrieve 
clinical data from the medical chart of women who got 
pregnant under dialysis. The main investigator collected 
all information and then inserted data in an Excel (Excel 2) 
spreadsheet elaborated for this investigation. After 
consistency checking, further analyses were performed 
assuming a significance level of 5% and the software 
used was SAS, version 9.02.
Data were manually collected by the researchers through 
review of medical records, employing a form specifically 
created for this study. Later, they were put in an Excel 2 
worksheet, also designed especially for this research.
Completed forms were appropriately filed to be ac-
cessible for quality control and identification of possible 
inconsistencies in the data. Review of the database was 
done to identify inconsistencies.
There was a 5% level of significance, and the software 
used for analysis was SAS, version 9:02. Variables consid-
ered included: maternal age, duration of pre-pregnancy 
dialysis, causes of CKD, number of prenatal visits, body 
mass index (BMI), number of previous pregnancies, 
use of anti-hypertensive medication during gestation, 
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maternal and fetal complications in pregnancy, mode 
of delivery, and neonatal outcomes.
This manuscript was approved by Unicamp and 
National Ethics Committee under the number: CAAE 
15152413.1.0000.5404, from May 28th 2013.
Results
Among the 16 women identified, 2 were excluded due 
to follow-up loss. In the remaining 14 ones with CKD who 
were undergoing dialysis, hypertension as probable etiol-
ogy of CKD was seen in half (7) of the cases. Most women 
(71.4%) had been on dialysis for more than one year and all 
of them performed 5 to 6 hemodialysis sessions per week.
Other comorbidities included: 11 cases of hyper-
tension, from which 1 subject had diabetes and 6 were 
current smokers. Five women had history of one previ-
ous Cesarean (C)-section (35.7%) and 3 had 2 or more 
(21.4%). Other data regarding characteristics of the 
participants are described in Table 1. The most widely 
Table 1. Characteristics of women who became pregnant on hemodialysis
Characteristics Means SD
Age (years) 30.4 ±5.4
Months in hemodialysis (pre-gestational) 23 ±15.0
Number of visits during prenatal care 6.5 ±3.6
Weight at the beginning of prenatal care 65.56 ±12.26
Weight at the end of prenatal care 70.94 ±14.76
n %
Skin color (white) 10 (62.5)
Schooling (less than secondary school) 9 64.3
Not employed 11 73.3
BMI at first prenatal visit (kg/m²)*
Underweight 1 6.25
Normal weight 9 56.25
Overweight 5 31.25
Obesity 1 6.25
Number of pregnancies (including current)
1 2 12.5
2 3 18.75
3 or more 11 68.75
Number of previous deliveries
0 2 12.5
1 8 50.0
2 or more 6 37.5
Causes of chronic renal failure
Hypertension 7 43.75
Glomerular disease 4 25.0
Pyelonephritis 1 6.25
Other causes 4 25.0
Antihypertensive treatment during pregnancy 12 75
Use of erythropoietin during pregnancy 8 53.3
*IOM (2009); BMI: body mass index.
Table 2. Perinatal outcomes in women who became pregnant on hemodialysis
Perinatal outcomes n %
Complications during pregnancy*
Preterm labor 6 42.9
Polyhydramnios 5 35.7
Fetal growth restriction 3 21.4
Hypertension 13 92.9
Gestational age at delivery
Less than 30 weeks 2 14.3
30 to 33 + 6 weeks 2 14.3
34 to 36 + 6 weeks 6 42.9
37 or more weeks 4 28.6
Birth weight
<2,500 g 11 78.6
>2,500 g 3 21.4
Mode of delivery
Vaginal 4 28.6
C-section 10 71.4
*some women had more than one complication.
used antihypertensive treatment was alpha-methyldopa 
(data not shown in table).
We evaluated gestational outcomes in the women 
who became pregnant while receiving hemodialysis 
treatment. One of them (the worst outcome in this 
series) developed malignant hypertension, with FGR and 
preterm delivery at 29 weeks for fetal distress. During 
pregnancy, two cases of abruption placenta occurred 
and two women had an acute pulmonary edema. The 
mode of delivery was C-section in 9 women (64.3%) 
and all of them chose to undergo tubal ligation at 
time of delivery. Cesarean indications were previous 
C-section in 3 of them, abruption placenta in 2, fetal 
distress 2 two and worsening maternal condition in 
2 subjects. All neonates had Apgar score at five min-
utes above 7. The mean weight of birth was 2,099 g. 
Further results for perinatal outcomes in women who 
became pregnant undergoing hemodialysis are shown 
in Table 2.
Discussion
Maternal and neonatal outcomes in women who 
became pregnant undergoing hemodialysis treatment pre-
sented in this series of cases are worse than in the general 
population. However, a few decades ago the occurrence 
of pregnancy in these women was not even possible. 
Changes in renal replacement therapy allowed relevant 
improvement in their health and therefore in their quality 
of life. Therefore, pregnancies, even if mostly unplanned, 
began to occur.
8 Rev Bras Ginecol Obstet. 2015; 37(1):5-9
Suarez MB, Costa ML, Parpinelli MA, Surita FG
In our study, the main causes of CKD in these women 
were chronic hypertension and glomerular disease. With 
the improvement of renal replacement therapy in the 
last 20 years, the percentage of women of childbearing 
age increased from 10 to 42%6. Thus, the pregnancy 
prevalence of women on dialysis is expected to increase, 
showing the importance of the topic. It is known that 
the rate of live births in this group of women have 
increased 40 to 50%, but the neonatal mortality rate 
remains high (8–13%)4,5.
In our series, 7/14 women had hypertension as the 
cause of kidney function loss. During pregnancy, 11 
women needed antihypertensive treatment throughout 
it and one of them used only late in pregnancy by the 
occurrence of preeclampsia. An Italian series that followed 
23 women found similar results with half of the patients 
being hypertensive at the beginning of pregnancy (12/22 
with available data), and 14/22 were hypertensive in 
pregnancy and throughout this study there was even a 
maternal death from cerebral hemorrhage (1 year after 
delivery)11.
Pregnancy, itself, may aggravate CKD. The most 
important determinant of renal function are the creatinine 
levels, which decrease during pregnancy when compared 
to preconception levels5 and many studies have targeted 
the best values as limits to indicate renal replacement 
therapy. Women with creatinine levels between 1.2 and 
1.4 mg/dL have a greater risk for gestational adverse 
outcomes than those with normal renal function. When 
pre-conception creatinine level is in the range of 1.4 to 
2.5 mg/dL, there is a risk of 20 to 30% of preeclampsia 
and preterm delivery. However, if they are higher than 
2.5 mg/dL, women should be discouraged from getting 
pregnant, since they would have a 70% risk of preterm 
delivery, 40% of preeclampsia, and 40% of decrease in 
renal function, either during pregnancy or in the post-
partum period, foremost indicating dialisys2,5. Ideally, 
therefore, the preconception creatinine level target is 
less than 1.2 mg/dL.
It is known that, when necessary, dialysis should be 
rapidly instituted since urea, creatinine and other me-
tabolites cross the placenta. Thus, the number of dialysis 
sessions should be increased (from 5 to 7 per week) and 
extended for a minimum of 20 hours per week, target-
ing plasmatic a urea level of 30–50 mg/dL5,7,8. Moreover, 
with more frequent sessions, less volume is withdrawn in 
each session, reducing the risk of maternal hypotension 
and its fetal impact3,8.
The implementation of more frequent dialysis ses-
sions (5 to 6 per week), use of erythropoietin and control 
of hypertension, maternal and neonatal outcomes were 
satisfactory, although the complications were higher than 
in the general population, as showed in this study.
The most common complications herein were 
worsening maternal hypertension, polyhydramnios 
and pre-term labor, as well as shown in recent litera-
ture12. One woman (the worst outcome in this series) 
developed malignant hypertension, with fetal growth 
restriction, preterm delivery at 29 weeks for fetal 
distress. Others due to maternal hypertension in this 
study were 2 abruption placentas and 2 women with 
acute pulmonary edema13.
The occurrence of polyhydramnios in this group 
is probably related to maternal uremia. An important 
cause of preterm labor in CKD under hemodialysis 
during pregnancy is polyhydramnios and this occurs 
mainly for two reasons: hypovolemia during dialysis 
causes decreased oncotic pressure and increased ma-
ternal urea leading to osmotic diuresis of the fetus2,14. 
The incidence of polyhydramnios is estimated around 
30–70% of these cases7.
Prematurity, either resulting from preterm labor or 
anticipated resolution due to maternal indications, is 
the major cause of neonatal morbidity and mortality10,15. 
In our study, 49.2% of women had pre-term labor, and 
71.5% (10/14) delivered under 37 complete weeks of 
gestation, however only 4 of 14 had it in 34 weeks 
of gestation.
Our neonatal outcomes were better than the ones 
of a Chilean series of 6 cases that had all preterm births 
with an average gestational age of 33 weeks (±1.7). In this 
study, the most common cause of pregnancy termina-
tion was intrahepatic cholestasis of pregnancy, in 4 of 
the 6 cases. This is a serious complication of pregnancy, 
however it did not occur in any of the cases followed in 
our institution. One case of oligohydramnios, other of 
polyhydramnios and 1 intrauterine growth restriction 
were also recorded16.
In addition, regarding prematurity, which is the most 
relevant neonatal complication among women with CKD 
undergoing hemodialysis, the Italian series found 19/21 
preterm, being 7/21 below 34 weeks, average weight 
and gestational age of the newborns were also worse than 
those found in our study11.
A recent large case series with 22 Canadian and 70 
American women provided better results. For the group 
of the Canadians cohort, the live birth rate (86.4%) was 
significantly higher than the rate in the American cohort 
(61.4%). Gestational age at delivery was 36 weeks (32–37) 
for the Canadian cohort compared with 27 ones (21–35) 
in the American. This study concludes that pregnancy 
may be safe and feasible in women receiving intensive 
hemodialysis17.
No one knows for sure if the relation between the 
onset of preterm labor during hemodialysis is, indeed, 
a consequence of this treatment. However, it is known 
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that there is a decrease in serum progesterone during 
this procedure of about 10%, and this could be one of 
multiple justifications for early labor8.
Concerning the mode of delivery, in this study, as 
well as previously reported in the literature, C-sections 
are more common4,6. In that series, it occurred in 64.3% 
of women, better than the 100% reported in the Chilean 
cohort16. Cesarean indications were previous C-section 
in 3 of them, abruption placenta in 2, fetal distress in 2 
and clinical maternal condition in 2. In one Chilean 
series, all six cases being followed-up were delivered 
by C-section.
Regarding neonatal outcome, all neonates had Apgar 
score at five minutes above 7, the average birth weight 
was 2,099 g and 71.5% were preterm (gestational age at 
delivery under 37 weeks). Due to the complications of 
hypertension, LBW was normally found in this group 
of women4,9. As said before, the rate of perinatal compli-
cations still remains high.
To improve prognosis, the following are needed: a 
multidisciplinary team, strict control of serum urea and 
hemoglobin levels, and also maternal blood pressure as 
well as close monitoring of fetal growth and vitality4.
Another important strategy is the preconception 
guidance. All women undergoing dialysis should 
be counseled about the possibility of pregnancy 
and its risks, and should use contraception to avoid 
unwanted pregnancies1. If they become pregnant, 
immediate referral is needed towards a high-risk 
prenatal multidisciplinary team prepared for pos-
sible complications.
A limitation of this study is the restricted number 
of cases. Although it is an increasing condition, due to 
better assistance, more women undertaking dialysis are 
becoming pregnant; however, it is still rare.
The evolution of renal replacement therapy had an 
important impact in the fertility rate of women under 
CKD, and, therefore, pregnancy rate. Studies show that 
more frequency and more prolonged hemodialysis, as 
well as follow-up with multidisciplinary teams improve 
gestational results. However, perinatal complications 
remain high, specially worsening of maternal hyper-
tension, polyhydramnios, and preterm births and its 
consequences.
Therefore, more studies need to be performed in order 
to compare different populations around the world and 
several dialysis control methods, probably as a multicenter 
study, enabling us to learn more about the outcomes and 
therapeutics. Obstetricians should be prepared for the 
increase in this condition.
